The expression of TGFB1 (Transforming Growth Factor Beta 1) was found to be significantly reduced in patients with mild COVID-19 symptoms as well as those who required intensive care unit (ICU) level care, in comparison to individuals who were not affected by COVID-19 (Zhou et al., 2021). Here, TGFB1 is linked to COVID-19.